MedTrace Logo

Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma

NCT01490801 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-05-17

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial studies biomarkers in blood and tissue samples from patients with Epstein-Barr virus positive Hodgkin lymphoma.

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

RNA analysis

GENETIC

cytogenetic analysis

GENETIC

in situ hybridization

GENETIC

mutation analysis

GENETIC

polymerase chain reaction

GENETIC

western blotting

OTHER

flow cytometry

OTHER

immunohistochemistry staining method

OTHER

medical chart review

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Kim E. Nichols, MD, BA · Children's Hospital of Philadelphia

Eligibility

Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2016-05-31
Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01490801 on ClinicalTrials.gov